EP01572 is a peptidomimetic growth hormone secretagogue, which has potent GH-releasing
activity after intravenous administration.It is an analogue of the natural compound ghrelin.
Since an oral delivery system would be preferable in many of the possible therapeutic
indications, the pharmacological profile and the GH-releasing activity of increasing single,
oral doses of EP01572 in healthy volunteers will be evaluated. In addition, the
pharmacokinetics and pharmacological effects of EP01572 will be investigated after
intraduodenal administration.